Cargando…

Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats

Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH’s and its primary metabolite nor-mephedrone’s (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Šíchová, Klára, Pinterová, Nikola, Židková, Monika, Horsley, Rachel R., Lhotková, Eva, Štefková, Kristýna, Vejmola, Čestmír, Uttl, Libor, Balíková, Marie, Kuchař, Martin, Páleníček, Tomáš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767720/
https://www.ncbi.nlm.nih.gov/pubmed/29375408
http://dx.doi.org/10.3389/fpsyt.2017.00306
_version_ 1783292577593688064
author Šíchová, Klára
Pinterová, Nikola
Židková, Monika
Horsley, Rachel R.
Lhotková, Eva
Štefková, Kristýna
Vejmola, Čestmír
Uttl, Libor
Balíková, Marie
Kuchař, Martin
Páleníček, Tomáš
author_facet Šíchová, Klára
Pinterová, Nikola
Židková, Monika
Horsley, Rachel R.
Lhotková, Eva
Štefková, Kristýna
Vejmola, Čestmír
Uttl, Libor
Balíková, Marie
Kuchař, Martin
Páleníček, Tomáš
author_sort Šíchová, Klára
collection PubMed
description Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH’s and its primary metabolite nor-mephedrone’s (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum, brain, lungs, and liver), as well as comparative analysis of their effects on locomotion [open field test (OFT)] and sensorimotor gating [prepulse inhibition of acoustic startle reaction (PPI ASR)]. Furthermore, in order to mimic the crowded condition where MEPH is typically taken (e.g., clubs), the acute effect of MEPH on thermoregulation in singly- and group-housed rats was evaluated. Pharmacokinetics of MEPH and nor-MEPH after MEPH (5 mg/kg, sc.) were analyzed over 8 h using liquid chromatography with mass spectrometry. MEPH (2.5, 5, or 20 mg/kg, sc.) and nor-MEPH (5 mg/kg, sc.) were administered 5 or 40 min before the behavioral testing in the OFT and PPI ASR; locomotion and its spatial distribution, ASR, habituation and PPI itself were quantified. The effect of MEPH on rectal temperature was measured after 5 and 20 mg/kg, sc. Both MEPH and nor-MEPH were detected in all substrates, with the highest levels detected in lungs. Mean brain: serum ratios were 1:1.19 (MEPH) and 1:1.91 (nor-MEPH), maximum concentrations were observed at 30 min; at 2 and 4 h after administration, nor-MEPH concentrations were higher compared to the parent drug. While neither of the drugs disrupted PPI, both increased locomotion and affected its spatial distribution. The effects of MEPH were dose dependent, rapid, and short-lasting, and the intensity of locomotor stimulant effects was comparable between MEPH and nor-MEPH. Despite the disappearance of behavioral effects within 40 min after administration, MEPH induced rectal temperature elevations that persisted for 3 h even in singly housed rats. To conclude, we observed a robust, short-lasting, and most likely synergistic stimulatory effect of both drugs which corresponded to brain pharmacokinetics. The dissociation between the duration of behavioral and hyperthermic effects is indicative of the possible contribution of nor-MEPH or other biologically active metabolites. This temporal dissociation may be related to the risk of prolonged somatic toxicity when stimulatory effects are no longer present.
format Online
Article
Text
id pubmed-5767720
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57677202018-01-26 Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats Šíchová, Klára Pinterová, Nikola Židková, Monika Horsley, Rachel R. Lhotková, Eva Štefková, Kristýna Vejmola, Čestmír Uttl, Libor Balíková, Marie Kuchař, Martin Páleníček, Tomáš Front Psychiatry Psychiatry Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH’s and its primary metabolite nor-mephedrone’s (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum, brain, lungs, and liver), as well as comparative analysis of their effects on locomotion [open field test (OFT)] and sensorimotor gating [prepulse inhibition of acoustic startle reaction (PPI ASR)]. Furthermore, in order to mimic the crowded condition where MEPH is typically taken (e.g., clubs), the acute effect of MEPH on thermoregulation in singly- and group-housed rats was evaluated. Pharmacokinetics of MEPH and nor-MEPH after MEPH (5 mg/kg, sc.) were analyzed over 8 h using liquid chromatography with mass spectrometry. MEPH (2.5, 5, or 20 mg/kg, sc.) and nor-MEPH (5 mg/kg, sc.) were administered 5 or 40 min before the behavioral testing in the OFT and PPI ASR; locomotion and its spatial distribution, ASR, habituation and PPI itself were quantified. The effect of MEPH on rectal temperature was measured after 5 and 20 mg/kg, sc. Both MEPH and nor-MEPH were detected in all substrates, with the highest levels detected in lungs. Mean brain: serum ratios were 1:1.19 (MEPH) and 1:1.91 (nor-MEPH), maximum concentrations were observed at 30 min; at 2 and 4 h after administration, nor-MEPH concentrations were higher compared to the parent drug. While neither of the drugs disrupted PPI, both increased locomotion and affected its spatial distribution. The effects of MEPH were dose dependent, rapid, and short-lasting, and the intensity of locomotor stimulant effects was comparable between MEPH and nor-MEPH. Despite the disappearance of behavioral effects within 40 min after administration, MEPH induced rectal temperature elevations that persisted for 3 h even in singly housed rats. To conclude, we observed a robust, short-lasting, and most likely synergistic stimulatory effect of both drugs which corresponded to brain pharmacokinetics. The dissociation between the duration of behavioral and hyperthermic effects is indicative of the possible contribution of nor-MEPH or other biologically active metabolites. This temporal dissociation may be related to the risk of prolonged somatic toxicity when stimulatory effects are no longer present. Frontiers Media S.A. 2018-01-10 /pmc/articles/PMC5767720/ /pubmed/29375408 http://dx.doi.org/10.3389/fpsyt.2017.00306 Text en Copyright © 2018 Šíchová, Pinterová, Židková, Horsley, Lhotková, Štefková, Vejmola, Uttl, Balíková, Kuchař and Páleníček. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Šíchová, Klára
Pinterová, Nikola
Židková, Monika
Horsley, Rachel R.
Lhotková, Eva
Štefková, Kristýna
Vejmola, Čestmír
Uttl, Libor
Balíková, Marie
Kuchař, Martin
Páleníček, Tomáš
Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
title Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
title_full Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
title_fullStr Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
title_full_unstemmed Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
title_short Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
title_sort mephedrone (4-methylmethcathinone): acute behavioral effects, hyperthermic, and pharmacokinetic profile in rats
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767720/
https://www.ncbi.nlm.nih.gov/pubmed/29375408
http://dx.doi.org/10.3389/fpsyt.2017.00306
work_keys_str_mv AT sichovaklara mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT pinterovanikola mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT zidkovamonika mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT horsleyrachelr mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT lhotkovaeva mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT stefkovakristyna mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT vejmolacestmir mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT uttllibor mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT balikovamarie mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT kucharmartin mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats
AT palenicektomas mephedrone4methylmethcathinoneacutebehavioraleffectshyperthermicandpharmacokineticprofileinrats